Medication info
Jadiflozin M Tablet 5/1000 mg (Empagliflozin, Metformin Hydrochloride)

Jadiflozin M Tablet 5/1000 mg (Empagliflozin, Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›5mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Youngpoong Pharmaceutical Co., Ltd.
Appearance
Yellow, biconvex, oval film-coated tablet with a brown hue.
Packaging
10 tablets/box (10 tablets/PTP x 1), 60 tablets/box (10 tablets/PTP x 6), 30 tablets/bottle, 60 tablets/bottle
Approval status
Active

MFDS item code 202201354 · Approved 2022.04.04 · Insurance code 661905700

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient’s current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each active ingredient: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medicines, such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient’s current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive the same doses of empagliflozin and metformin that they were taking previously. When this medicine is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If a dose of this medicine is missed, take it as soon as remembered. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Youngpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • poor blood glucose control
  • cardiovascular disease
  • cardiovascular events
View approved original text

This medication is used to help control blood glucose levels in adults with type 2 diabetes when empagliflozin and metformin are administered in combination. It particularly aids in effective blood glucose management alongside dietary and exercise therapy. This medication may also be used in adult type 2 diabetes patients with cardiovascular disease whose blood glucose is poorly controlled, but should be used cautiously following expert clinical trial information. Overall, this medication is useful for improving blood glucose control in patients with type 2 diabetes.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient’s current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each active ingredient: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medicines, such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient’s current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive the same doses of empagliflozin and metformin that they were taking previously. When this medicine is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If a dose of this medicine is missed, take it as soon as remembered. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual single-ingredient products, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Precautions

This medication helps manage blood glucose levels. While taking this medication, there may be a risk of a rare side effect known as severe lactic acidosis. Lactic acidosis can lead to excessive lactate buildup in the body and can be dangerous, so if symptoms occur, consult a physician immediately. Additionally, hypoglycemia may occur when taken alongside insulin or other diabetes medications, so blood glucose levels should be monitored frequently. This medication should not be taken by patients with severely impaired kidney function, acute infections, dehydration, or severe cardiac issues. If iodine contrast is administered for radiological examinations, this medication should be paused for a certain period before and after the test, and it should only be resumed after confirming normal kidney function. It is safest for pregnant or nursing women to avoid this medication. Elderly patients or those with impaired kidney function should undergo kidney function tests before taking this medication and have their kidney function monitored regularly. This medication may increase urination and raise the risk of urinary tract infections or genital infections, so inform a physician immediately if related symptoms occur. Sufficient hydration is necessary due to the risk of dehydration or hypotension while taking this medication, and if there are severe diarrhea or vomiting, the medication should be temporarily paused and a physician consulted. Vitamin B12 levels may decrease over time, so it's advisable to monitor vitamin B12 status with blood tests if taken for an extended period. Alcohol consumption may increase the risk of side effects from this medication, so it is advisable to avoid excessive drinking during treatment. Specific blood glucose tests (such as 1,5-AG tests) are not recommended to accurately assess blood glucose control during medication use. If symptoms of hypoglycemia occur, consume sugar immediately, and if symptoms are severe, visit a medical institution. Patients scheduled for surgery should stop taking this medication 48 hours before surgery and should only resume after confirming normal kidney function post-surgery. This medication is not recommended for children and may require dose adjustments for the elderly. In the case of overdose, professional treatment such as dialysis may be necessary, so it's crucial to adhere to the prescribed doses.

Side effects

  • Hypoglycemia
  • urinary tract infection
  • genital infection
  • increased urination
  • nausea
  • vomiting
  • diarrhea
  • abdominal pain
  • loss of appetite
  • constipation
Show 249 more
  • abnormal liver function tests
  • hepatitis
  • altered taste
  • itching
  • rash
  • urticaria
  • erythema
  • angioedema
  • difficulty urinating
  • interstitial nephritis
  • thirst
  • increased serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • ketoacidosis
  • lactic acidosis
  • decreased fluid volume
  • fluid loss
  • low blood pressure
  • hypotension
  • decreased blood volume
  • orthostatic hypotension
  • syncope
  • perineal necrosis
  • vulvovaginitis
  • balanitis
  • pyelonephritis
  • urosepsis
  • rash
  • urticaria
  • angioedema
  • nausea
  • malaise
  • diarrhea
  • gastric ulcer
  • colitis
  • gastritis
  • abdominal discomfort
  • fecal incontinence
  • dry mouth
  • gastrointestinal disturbance
  • gastroesophageal reflux disease
  • oral discomfort
  • salivary gland pain
  • headache
  • sensory decrease
  • positional dizziness
  • dizziness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • weight loss
  • urinary stones
  • hematuria
  • overactive bladder
  • kidney mass
  • urinary retention
  • urinary pain
  • abnormal urination
  • vulvar pruritus
  • benign prostatic hyperplasia
  • diabetic retinopathy
  • diplopia
  • hypertension
  • myocardial infarction
  • insomnia
  • anxiety
  • depression
  • sleep disorders
  • dysmenorrhea
  • positional vertigo
  • vertigo
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid mass
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • diabetic foot
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • glaucoma
  • macular fibrosing
  • ocular discomfort
  • eye congestion
  • pathological myopia
  • retinal detachment
  • retinal deposits
  • retinal vein occlusion
  • lattice retinal detachment
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • residual sputum
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • fall
  • hand fracture
  • iliotibial band syndrome
  • open eye injury
  • pelvic fracture
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • palpitations
  • Prinzmetal angina
  • coronary artery disease
  • tachycardia
  • atherosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral artery occlusive disease
  • cervicitis
  • erectile dysfunction
  • atrophic vaginitis
  • cervical dysplasia
  • vaginal discharge
  • hypoglycemia
  • decreased appetite
  • obesity
  • hyperlipidemia
  • dyslipidemia
  • hyperglycemia
  • diabetes mellitus
  • weight gain
  • electrocardiogram abnormalities
  • decreased hemoglobin
  • increased hemoglobin
  • positive Helicobacter test
  • positive urinary red blood cells
  • upper abdominal pain
  • cavities
  • erosive gastritis
  • abdominal distension
  • rectal bleeding
  • chronic gastritis
  • ischemic colitis
  • enteritis
  • flatulence
  • gastric polyps
  • gingival swelling
  • blood in stool
  • hemorrhoids
  • colonic bleeding
  • pancreatic cyst
  • rectal pain
  • toothache
  • upper respiratory infection
  • bronchitis
  • chronic sinusitis
  • gastroenteritis
  • Helicobacter infection
  • periodontitis
  • chronic tonsillitis
  • conjunctivitis
  • influenza
  • laryngitis
  • chronic otitis media
  • paronychia
  • peritonsillar abscess
  • tinea capitis
  • dental abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • nasopharyngitis
  • herpes zoster
  • drowsiness
  • CNS-origin dizziness
  • amnesia
  • carotid artery stenosis
  • diabetic neuropathy
  • facial paralysis
  • intracranial aneurysm
  • memory impairment
  • neuralgia
  • parkinsonism
  • polyneuropathy
  • sensory disturbances
  • fatigue
  • peripheral edema
  • facial edema
  • peripheral swelling
  • chills
  • strange sensations
  • swelling
  • pain
  • pain at the puncture site
  • vascular stent thrombosis
  • chest pain
  • unstable angina
  • hypercholesterolemia
  • vitamin D deficiency
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pulmonary tuberculosis
  • acute pyelonephritis
  • sepsis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • dysmenorrhea
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid mass

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a closed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. This will help preserve the medication's effectiveness and safety over time.

Appearance and packaging

Appearance

Yellow, biconvex, oval film-coated tablet with a brown hue.

Package unit

10 tablets/box (10 tablets/PTP x 1), 60 tablets/box (10 tablets/PTP x 6), 30 tablets/bottle, 60 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.